News
Merck aims to boost its business by buying Verona Pharma for $10 billion. Through the deal, it will add Ohtuvayre -- a ...
19h
MedPage Today on MSNNovel Immunotherapy Shows Early Promise in Melanoma Resistant to PD-1 BlockadeMedian progression-free survival was 3.7 months, with 44.4% of patients being progression free at 6 months and 32.3% at 12 ...
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
Health and Human Services Secretary Robert F. Kennedy Jr. lambasted federal agencies he accused of being overly influenced by ...
MSFT, BABA, and MRK lead today's top analyst picks, with AI, e-commerce, and cancer drug strategies in sharp focus.
Merck & Co., Inc. outshines Gilead Sciences, Inc. with stronger dividend growth, valuation metrics & PEGY ratio. Click for ...
1don MSN
Merck & Co., Inc. (NYSE:MRK), one of the largest pharmaceutical companies in the world, has lost 15% year-to-date on the ...
Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a trial last year, the firm’s cancer drug outperformed the world’s best ...
From J&J to BMS, New Jersey pharmaceutical companies continue to expand and transform through M&A, leadership shifts and regional growth.
Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Merck & Co., Inc. (NYSE:MRK) is ...
Merck, a leading science and technology company, has launched the AAW™ Automated Assay Workstation, a solution powered by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results